Fluticasone Furoate/Vilanterol: a Review of Its Use in Patients with Asthma
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fluticasone Furoate/Vilanterol: a Review of Its Use in Patients with Asthma
Authors
Keywords
Fluticasone, Fluticasone Propionate, Furoate, Fluticasone Furoate, Severe Asthma Exacerbation
Journal
DRUGS
Volume 75, Issue 4, Pages 407-418
Publisher
Springer Nature
Online
2015-02-03
DOI
10.1007/s40265-015-0354-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Suppression of Cytokine Release by Fluticasone Furoate vs. Mometasone Furoate in Human Nasal Tissue Ex-Vivo
- (2014) Nan Zhang et al. PLoS One
- Pharmacokinetics and pharmacodynamics of intravenous and inhaled fluticasone furoate in healthy Caucasian and East Asian subjects
- (2013) Ann Allen et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- A repeat-dose thorough QT study of inhaled fluticasone furoate/vilanterol combination in healthy subjects
- (2013) Rodger Kempsford et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Efficacy and Safety of Fluticasone Furoate/Vilanterol Compared With Fluticasone Propionate/Salmeterol Combination in Adult and Adolescent Patients With Persistent Asthma
- (2013) Ashley Woodcock et al. CHEST
- Inhaled fluticasone furoate/vilanterol does not affect hypothalamic-pituitary-adrenal axis function in adolescent and adult asthma: randomised, double-blind, placebo-controlled study
- (2013) Ann Allen et al. Clinical Respiratory Journal
- Once-daily fluticasone furoate alone or combined with vilanterol in persistent asthma
- (2013) P. M. O'Byrne et al. EUROPEAN RESPIRATORY JOURNAL
- The efficacy of once-daily fluticasone furoate/vilanterol in asthma is comparable with morning or evening dosing
- (2013) Rodger D. Kempsford et al. RESPIRATORY MEDICINE
- Safety and tolerability of the novel inhaled corticosteroid fluticasone furoate in combination with the β2agonist vilanterol administered once daily for 52 weeks in patients ≥12 years old with asthma: a randomised trial
- (2013) William W Busse et al. THORAX
- Once-daily fluticasone furoate (FF)/vilanterol reduces risk of severe exacerbations in asthma versus FF alone
- (2013) Eric D Bateman et al. THORAX
- Qualitative assessment of attributes and ease of use of the ELLIPTA™ dry powder inhaler for delivery of maintenance therapy for asthma and COPD
- (2013) Henrik Svedsater et al. BMC Pulmonary Medicine
- Once-daily fluticasone furoate is efficacious in patients with symptomatic asthma on low-dose inhaled corticosteroids
- (2012) Eugene R. Bleecker et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- The effect of ketoconazole on the pharmacokinetics and pharmacodynamics of inhaled fluticasone furoate and vilanterol trifenatate in healthy subjects
- (2012) Rodger Kempsford et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Fluticasone Furoate, a Novel Inhaled Corticosteroid, Demonstrates Prolonged Lung Absorption Kinetics in Man Compared with Inhaled Fluticasone Propionate
- (2012) Ann Allen et al. CLINICAL PHARMACOKINETICS
- Influence of Renal and Hepatic Impairment on the Pharmacokinetic and Pharmacodynamic Properties and Tolerability of Fluticasone Furoate and Vilanterol in Combination
- (2012) Ann Allen et al. CLINICAL THERAPEUTICS
- 24-h duration of the novel LABA vilanterol trifenatate in asthma patients treated with inhaled corticosteroids
- (2012) Jan Lötvall et al. EUROPEAN RESPIRATORY JOURNAL
- Vilanterol trifenatate, a novel inhaled long-acting beta2 adrenoceptor agonist, is well tolerated in healthy subjects and demonstrates prolonged bronchodilation in subjects with asthma and COPD
- (2012) Rodger Kempsford et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Dose effect of once-daily fluticasone furoate in persistent asthma: A randomized trial
- (2012) Eric D. Bateman et al. RESPIRATORY MEDICINE
- Efficacy and optimal dosing interval of the long-acting beta2 agonist, vilanterol, in persistent asthma: A randomised trial
- (2012) Richard Sterling et al. RESPIRATORY MEDICINE
- Combined fluticasone furoate/vilanterol reduces decline in lung function following inhaled allergen 23 h after dosing in adult asthma: a randomised, controlled trial
- (2012) Amanda Oliver et al. Clinical and Translational Allergy
- Long-acting fluticasone furoate has a superior pharmacological profile to fluticasone propionate in human respiratory cells
- (2011) Christos Rossios et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Fluticasone furoate demonstrates efficacy in patients with asthma symptomatic on medium doses of inhaled corticosteroid therapy: an 8-week, randomised, placebo-controlled trial
- (2011) William W Busse et al. THORAX
- Metabolism and Disposition of Fluticasone Furoate, an Enhanced-Affinity Glucocorticoid, in Humans
- (2008) S. C. Hughes et al. DRUG METABOLISM AND DISPOSITION
- X-ray Crystal Structure of the Novel Enhanced-Affinity Glucocorticoid Agonist Fluticasone Furoate in the Glucocorticoid Receptor−Ligand Binding Domain⊥
- (2008) Keith Biggadike et al. JOURNAL OF MEDICINAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now